Mark S. Graham

Array ( [id] => 7275619 [patent_doc_number] => 20040235070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy' [patent_app_type] => new [patent_app_number] => 10/671328 [patent_app_country] => US [patent_app_date] => 2003-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10032 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235070.pdf [firstpage_image] =>[orig_patent_app_number] => 10671328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269432 [patent_doc_number] => 20040057950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases' [patent_app_type] => new [patent_app_number] => 10/661881 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5501 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20040057950.pdf [firstpage_image] =>[orig_patent_app_number] => 10661881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5661070 [patent_doc_number] => 20060251666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Cancer antigens and utilization thereof' [patent_app_type] => utility [patent_app_number] => 10/525831 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10838 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20060251666.pdf [firstpage_image] =>[orig_patent_app_number] => 10525831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7184457 [patent_doc_number] => 20050191631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Plus end-directed microtubule motor required for chromosome congression' [patent_app_type] => utility [patent_app_number] => 10/650280 [patent_app_country] => US [patent_app_date] => 2003-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21268 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191631.pdf [firstpage_image] =>[orig_patent_app_number] => 10650280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069022 [patent_doc_number] => 20050244405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Vascular endothelial cell growth factor antagonists and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/648816 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14968 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244405.pdf [firstpage_image] =>[orig_patent_app_number] => 10648816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387739 [patent_doc_number] => 20040082758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated' [patent_app_type] => new [patent_app_number] => 10/647005 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17937 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082758.pdf [firstpage_image] =>[orig_patent_app_number] => 10647005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 195515 [patent_doc_number] => 07635475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Diabody-type bispecific antibody' [patent_app_type] => utility [patent_app_number] => 10/642284 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 10911 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 469 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635475.pdf [firstpage_image] =>[orig_patent_app_number] => 10642284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306853 [patent_doc_number] => 20040116674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Separation of polypeptide monomers' [patent_app_type] => new [patent_app_number] => 10/642409 [patent_app_country] => US [patent_app_date] => 2003-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4894 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116674.pdf [firstpage_image] =>[orig_patent_app_number] => 10642409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6990497 [patent_doc_number] => 20050089534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Lipid enriched domains as vaccine targets in tumor therapy' [patent_app_type] => utility [patent_app_number] => 10/639667 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1337 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089534.pdf [firstpage_image] =>[orig_patent_app_number] => 10639667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7463590 [patent_doc_number] => 20040053276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Novel tissue-specific secretory polypeptide and dna thereof' [patent_app_type] => new [patent_app_number] => 10/381089 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 31837 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053276.pdf [firstpage_image] =>[orig_patent_app_number] => 10381089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127269 [patent_doc_number] => 20050059013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Use of biomarkers for detecting ovarian cancer' [patent_app_type] => utility [patent_app_number] => 10/635308 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25304 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059013.pdf [firstpage_image] =>[orig_patent_app_number] => 10635308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7220698 [patent_doc_number] => 20040072268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Methods for regulating BRCA1-BRCA2-containing complex activity' [patent_app_type] => new [patent_app_number] => 10/634574 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12201 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072268.pdf [firstpage_image] =>[orig_patent_app_number] => 10634574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7385757 [patent_doc_number] => 20040082510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Pyk2 phosphorylation by her3 induces tumor invasion' [patent_app_type] => new [patent_app_number] => 10/470842 [patent_app_country] => US [patent_app_date] => 2003-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10972 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082510.pdf [firstpage_image] =>[orig_patent_app_number] => 10470842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7243299 [patent_doc_number] => 20050271636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Diagnostic and therapeutic uses for prox 1' [patent_app_type] => utility [patent_app_number] => 10/523292 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7494 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271636.pdf [firstpage_image] =>[orig_patent_app_number] => 10523292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 833244 [patent_doc_number] => 07396533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-08 [patent_title] => 'Polypeptides and nucleic acids encoding same' [patent_app_type] => utility [patent_app_number] => 10/628770 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 25 [patent_no_of_words] => 29116 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/396/07396533.pdf [firstpage_image] =>[orig_patent_app_number] => 10628770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856677 [patent_doc_number] => 07374935 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Human Rgr oncogene and truncated transcripts thereof detected in T cell malignancies, antibodies to the encoded polypeptides and methods of use' [patent_app_type] => utility [patent_app_number] => 10/625471 [patent_app_country] => US [patent_app_date] => 2003-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 30 [patent_no_of_words] => 13073 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/374/07374935.pdf [firstpage_image] =>[orig_patent_app_number] => 10625471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7407920 [patent_doc_number] => 20040106161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies' [patent_app_type] => new [patent_app_number] => 10/619754 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 37377 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106161.pdf [firstpage_image] =>[orig_patent_app_number] => 10619754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7121983 [patent_doc_number] => 20050013812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Vaccines using pattern recognition receptor-ligand:lipid complexes' [patent_app_type] => utility [patent_app_number] => 10/621254 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33249 [patent_no_of_claims] => 150 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20050013812.pdf [firstpage_image] =>[orig_patent_app_number] => 10621254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 246758 [patent_doc_number] => 07585509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Erb-2 receptor targeting peptide' [patent_app_type] => utility [patent_app_number] => 10/520408 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 21800 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585509.pdf [firstpage_image] =>[orig_patent_app_number] => 10520408 [rel_patent_id] =>[rel_patent_doc_number] =>)